The Vanguard Mid-Cap Value ETF (VOE) shows an implied analyst target price of $192.89, suggesting a 10.02% upside from its recent trading price of $175.32, based on the average 12-month forward targets of its underlying holdings. Key constituents contributing to this outlook include Wabtec Corp (WAB), Clorox Co (CLX), and CBRE Group Inc (CBRE), which individually exhibit analyst-projected upsides of 11.96%, 11.20%, and 10.59% respectively. While these figures indicate potential growth according to analyst consensus, the article notes that these targets warrant further investor research to assess their justification and current relevance.
The Vanguard Mid-Cap Value ETF (VOE) presents an implied 10.02% upside to its average analyst 12-month forward target price, projecting $192.89 per unit from a recent trading price of $175.32. This aggregate target is derived from the weighted average of its underlying holdings' analyst targets, indicating a moderately positive outlook for the ETF. Specific constituents driving this positive outlook include Wabtec Corp (WAB), Clorox Co (CLX), and CBRE Group Inc (CBRE), each showing significant individual upside potential. WAB has an 11.96% upside to its $224.30 target, CLX an 11.20% upside to $128.44, and CBRE a 10.59% upside to $178.20. These figures highlight specific areas of perceived value within the ETF's portfolio. Despite the implied upsides and moderately positive sentiment (0.5 sentiment score), the article explicitly raises questions regarding the justification and recency of these analyst targets. It suggests that targets could be "relics of the past" and may warrant further investor research to assess their validity in light of current company and industry developments. This introduces a crucial element of caution for investors.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment
